Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

Disorders Stocks Recent News

Date Stock Title
May 9 PHAT Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates
May 9 PHAT Phathom Pharmaceuticals Non-GAAP EPS of -$1.11 beats by $0.06, revenue of $1.91M misses by $0.23M
May 9 PHAT Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 REGN Regeneron’s gene therapy triumphs twice, restoring hearing in children
May 8 REGN Regeneron gene therapy improves hearing in child deafness
May 8 REGN Regeneron gene therapy improves hearing in two children
May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
May 7 PXMD PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
May 7 VTGN Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 6 REGN Regeneron Announces Investor Conference Presentations
May 6 REGN Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
May 5 REGN Wall Street Breakfast: The Week Ahead
May 4 REGN 23 Most Profitable Stocks of the Last 12 Months
May 3 PTPI Petros Pharmaceuticals files $100M mixed securities shelf
May 3 PHAT Phathom a buy at Stifel on new heartburn therapy
May 3 REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
May 3 REGN Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
May 3 REGN Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
May 3 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
May 3 REGN Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
Disorders

Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

Browse All Tags